HomePCRX • NASDAQ
Pacira Biosciences Inc
add
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | 168.92M | 1.08% |
Operating expense | 124.55M | 21.18% |
Net income | 4.81M | -46.41% |
Net profit margin | 2.85 | -46.93% |
Earnings per share | 0.62 | 0.00% |
EBITDA | 28.99M | -13.56% |
Effective tax rate | 44.73% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 493.63M | 51.47% |
Total assets | 1.59B | 0.21% |
Total liabilities | 788.13M | 14.03% |
Total equity | 798.54M | — |
Shares outstanding | 46.30M | — |
Price to book | 1.56 | — |
Return on assets | 1.25% | — |
Return on capital | 1.37% | — |
Cash Flow
Net Change in Cash
Net change in cash
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Net income | 4.81M | -46.41% |
Cash from operations | 35.46M | -27.78% |
Cash from investing | -25.63M | -65.03% |
Cash from financing | -2.99M | -6.28% |
Net change in cash | 6.84M | -77.77% |
Free cash flow | 28.23M | -39.77% |
Previous close
$26.98
Day range
$26.24 - $27.15
Year range
$11.16 - $30.39
Market cap
1.23B USD
Avg Volume
827.37K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2006
Headquarters
Website
Employees
789